GIPL.US Global Innovative Platforms Inc

Financial Services Capital Markets USA Stocks
- USD
Market cap
-
P/E
-
P/B
-
ROE
-111.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2026.

Is GIPL.US undervalued?

Graham number

The Graham number of Global Innovative Platforms Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Global Innovative Platforms Inc fundamental analysis

No fundamental analysis for Global Innovative Platforms Inc yet.

Global Innovative Platforms Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Global Innovative Platforms Inc

Global Innovative Platforms Inc. engages in the business of testing breath to detect and assist in the treatment of disease. The company develops Heartworm breath test, which includes breath collection device, to collect shallow breath samples. It also operates VOCAM Plus and FROG platform for gas chromatography, as well as operates A.I. software to provide breath and air analysis. The company was formerly known as Canning Str Corp. and changed its name to Global Innovative …

Full company profile